Survival Outcomes For Patients With Metastatic Triple Negative Breast

  • Fourteen percent of patients presented with MBC. Twenty seven percent received neoadjuvant chemotherapy, and received adjuvant chemotherapy. CONCLUSION Despite the poorer overall prognosis of patients with triple negative disease, there remains considerable heterogeneity in individual outcomes..

  • Background. Clinical experience suggests that many women with triple negative metastatic breast MBC relapse quickly. This has implications for .

  • Clinical experience suggests that many women with triple negative metastatic breast MBC relapse quickly. This has implications for .

  • Clinical experience suggests that many women with triple negative metastatic breast MBC relapse quickly. This has implications for clinical practice and .

Survival outcomes for patients with metastatic triple negative breast

Loading

Image Result For Survival Outcomes For Patients With Metastatic Triple Negative Breast

Image Result For Survival Outcomes For Patients With Metastatic Triple Negative Breast